Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 25(13)2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38999958

ABSTRACT

Anticancer peptides (ACPs) are bioactive compounds known for their selective cytotoxicity against tumor cells via various mechanisms. Recent studies have demonstrated that in silico machine learning methods are effective in predicting peptides with anticancer activity. In this study, we collected and analyzed over a thousand experimentally verified ACPs, specifically targeting peptides derived from natural sources. We developed a precise prediction model based on their sequence and structural features, and the model's evaluation results suggest its strong predictive ability for anticancer activity. To enhance reliability, we integrated the results of this model with those from other available methods. In total, we identified 176 potential ACPs, some of which were synthesized and further evaluated using the MTT colorimetric assay. All of these putative ACPs exhibited significant anticancer effects and selective cytotoxicity against specific tumor cells. In summary, we present a strategy for identifying and characterizing natural peptides with selective cytotoxicity against cancer cells, which could serve as novel therapeutic agents. Our prediction model can effectively screen new molecules for potential anticancer activity, and the results from in vitro experiments provide compelling evidence of the candidates' anticancer effects and selective cytotoxicity.


Subject(s)
Antineoplastic Agents , Computer Simulation , Peptides , Humans , Peptides/pharmacology , Peptides/chemistry , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Cell Line, Tumor , Neoplasms/drug therapy , Neoplasms/pathology , Neoplasms/metabolism , Biological Products/pharmacology , Biological Products/chemistry , Cell Survival/drug effects , Machine Learning , Drug Screening Assays, Antitumor
2.
Taiwan J Obstet Gynecol ; 63(3): 402-404, 2024 May.
Article in English | MEDLINE | ID: mdl-38802207

ABSTRACT

OBJECTIVE: To discuss several techniques of hysteroscopic surgery for complete septate uterus. CASE REPORT: A 40-year-old female with unexplained primary infertility was diagnosed with complete septate uterus with septate cervix. Hysteroscopic incision of complete septate uterus was performed by using ballooning technique. The patient conceived naturally shortly after the operation and delivered a healthy, term infant. CONCLUSION: Hysteroscopic incision of complete septate uterus is a safe and prompt way of metroplasty. With the knowledge obtained from a pre-operative MRI, it can be completed without laparoscopy and the need for hospitalization.


Subject(s)
Cervix Uteri , Hysteroscopy , Uterus , Humans , Female , Adult , Hysteroscopy/methods , Pregnancy , Cervix Uteri/abnormalities , Cervix Uteri/surgery , Uterus/abnormalities , Uterus/surgery , Infertility, Female/surgery , Infertility, Female/etiology , Term Birth , Urogenital Abnormalities/surgery , Urogenital Abnormalities/diagnostic imaging , Septate Uterus
4.
Proteomics ; 24(9): e2300257, 2024 May.
Article in English | MEDLINE | ID: mdl-38263811

ABSTRACT

With the notable surge in therapeutic peptide development, various peptides have emerged as potential agents against virus-induced diseases. Viral entry inhibitory peptides (VEIPs), a subset of antiviral peptides (AVPs), offer a promising avenue as entry inhibitors (EIs) with distinct advantages over chemical counterparts. Despite this, a comprehensive analytical platform for characterizing these peptides and their effectiveness in blocking viral entry remains lacking. In this study, we introduce a groundbreaking in silico approach that leverages bioinformatics analysis and machine learning to characterize and identify novel VEIPs. Cross-validation results demonstrate the efficacy of a model combining sequence-based features in predicting VEIPs with high accuracy, validated through independent testing. Additionally, an EI type model has been developed to distinguish peptides specifically acting as Eis from AVPs with alternative activities. Notably, we present iDVEIP, a web-based tool accessible at http://mer.hc.mmh.org.tw/iDVEIP/, designed for automatic analysis and prediction of VEIPs. Emphasizing its capabilities, the tool facilitates comprehensive analyses of peptide characteristics, providing detailed amino acid composition data for each prediction. Furthermore, we showcase the tool's utility in identifying EIs against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).


Subject(s)
Antiviral Agents , Computational Biology , Machine Learning , Peptides , SARS-CoV-2 , Virus Internalization , Virus Internalization/drug effects , Antiviral Agents/pharmacology , Antiviral Agents/chemistry , Humans , Peptides/chemistry , Peptides/pharmacology , Computational Biology/methods , SARS-CoV-2/drug effects , COVID-19 Drug Treatment , Computer Simulation , COVID-19/virology , Software
SELECTION OF CITATIONS
SEARCH DETAIL